Cellectis S.A.

Cellectis S.A.verified

CLLS

Price:

$3.09

Market Cap:

$231.33M

Cellectis S.A. is a biotechnology firm in the clinical development stage, concentrating on the creation of immuno-oncology therapies. These therapies harness gene-edited T-cells engineered to express chimeric antigen receptors, designed to specifically identify and eliminate malignant cells. Its operations are divided into two distinct divisions: Therapeutics and Plants. The therapeutic pipeline includes several product candidates currently undergoing development. Among these is UCART19, an allogeneic T-cell therapy targeting CD19-expressing blood cancers such as acute lymphoblastic leukemia. Other key developments encompass ALLO-501 and ALLO-501A, designed for diffuse large B-cell lymphoma ...[Read more]

Industry

Biotechnology

IPO Date

2015-03-24

Stock Exchange

NASDAQ

Ticker

CLLS

The Enterprise Value as of June 2026 (TTM) for Cellectis S.A. (CLLS) is 304.86M

According to Cellectis S.A.’s latest financial reports and current stock price. The company's current Enterprise Value is 304.86M. This represents a change of -14.84% compared to the average of 357.98M of the last 4 quarters.

Cellectis S.A. (CLLS) Historical Enterprise Value (quarterly & annually)

How has CLLS Enterprise Value performed in the past?

The mean historical Enterprise Value of Cellectis S.A. over the last ten years is 396.75M. The current 304.86M Enterprise Value has changed 7.58% with respect to the historical average. Over the past ten years (40 quarters), CLLS's Enterprise Value was at its highest in in the December 2020 quarter at 1.11B. The Enterprise Value was at its lowest in in the December 2022 quarter at 81.72M.

Quarterly (TTM)
Annual

Average

396.75M

Median

304.09M

Minimum

81.98M

Maximum

1.11B

Cellectis S.A. (CLLS) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Cellectis S.A. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 424.60%

Maximum Annual Enterprise Value = 1.11B

Minimum Annual Increase = -73.31%

Minimum Annual Enterprise Value = 81.98M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2025523.91M424.60%
202499.87M-8.13%
2023108.70M32.59%
202281.98M-72.24%
2021295.28M-73.31%
20201.11B156.01%
2019432.12M70.69%
2018253.16M-66.39%
2017753.27M140.73%
2016312.91M-55.25%

Cellectis S.A. (CLLS) Average Enterprise Value

How has CLLS Enterprise Value performed in the past?

The current Enterprise Value of Cellectis S.A. (CLLS) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

3-year avg

244.16M

5-year avg

221.95M

10-year avg

396.75M

Cellectis S.A. (CLLS) Enterprise Value vs. Peers

How is CLLS’s Enterprise Value compared to its peers?

Cellectis S.A.’s Enterprise Value is less than Alto Neuroscience, Inc. (495.40M), greater than AC Immune S.A. (172.37M), greater than Aldeyra Therapeutics, Inc. (56.68M), greater than Amarin Corporation plc (189.73M), less than Alpha Tau Medical Ltd. (895.61M), greater than Larimar Therapeutics, Inc. (122.82M), less than Silence Therapeutics plc (310.47M), less than DBV Technologies S.A. (366.68M), greater than Mereo BioPharma Group plc (12.46M), greater than Korro Bio, Inc. (96.75M),

Build a custom stock screener for Cellectis S.A. (CLLS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cellectis S.A. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Cellectis S.A. (CLLS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Cellectis S.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Cellectis S.A.'s Enterprise Value?

What is the highest Enterprise Value for Cellectis S.A. (CLLS)?

What is the 3-year average Enterprise Value for Cellectis S.A. (CLLS)?

What is the 5-year average Enterprise Value for Cellectis S.A. (CLLS)?

How does the current Enterprise Value for Cellectis S.A. (CLLS) compare to its historical average?